Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy

Karen Kelly, Christopher G. Azzoli, Petr Zatloukal, István Albert, Peter Y Z Jiang, David Bodkin, José Rodrigues Pereira, Erzsébet Juhász, Nicholas O. Iannotti, Garry Weems, Tony Koutsoukos, Jyoti D. Patel

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences